102752-32-9

Basic information

• Product Name: diethyl 2-(3-(4-bromophenyl)-3-oxo-1-phenylpropyl)malonate
• Synonyms: diethyl 2-(3-(4-bromophenyl)-3-oxo-1-phenylpropyl)malonate
• CAS NO: 102752-32-9
• Molecular Weight: 447.326
• Mol File: 102752-32-9.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: diethyl 2-(3-(4-bromophenyl)-3-oxo-1-phenylpropyl)malonate(CAS DataBase Reference)
• NIST Chemistry Reference: diethyl 2-(3-(4-bromophenyl)-3-oxo-1-phenylpropyl)malonate(102752-32-9)
• EPA Substance Registry System: diethyl 2-(3-(4-bromophenyl)-3-oxo-1-phenylpropyl)malonate(102752-32-9)

Safety Data

• Hazardous Substances Data: 102752-32-9(Hazardous Substances Data)

Upstream product

• 2403-27-2 1-(4-bromophenyl)-3-phenyl-2-propen-1-one 
• 105-53-3 diethyl malonate 
• 99-90-1 para-bromoacetophenone 
• 100-52-7 benzaldehyde 
• 72758-69-1 (E)-1-(4-bromophenyl)-3-phenylprop-2-en-1-one 

Downstream Products

• 154356-85-1 5-(4-bromo-phenyl)-5-oxo-3-phenyl-valeric acid methyl ester 
• 861339-13-1 5-(4-bromo-phenyl)-5-oxo-3-phenyl-valeric acid 
• 72758-69-1 (E)-1-(4-bromophenyl)-3-phenylprop-2-en-1-one 
• 105-53-3 diethyl malonate 
• 861330-35-0 [3-(4-bromo-phenyl)-3-oxo-1-phenyl-propyl]-malonic acid 

Relevant articles and documents

ALLOSTERIC PROTEIN KINASE MODULATORS

The invention provides specific small molecule compounds that allosterically regulate the activity or modulate protein-protein interactions of AGC protein kinases and the Aurora family of protein kinases, methods for their production, pharmaceutical compositions comprising same, and their use for preparing medicaments for the treatment and prevention of diseases related to abnormal activities of AGC protein kinases or of protein kinases of the Aurora family.

ALLOSTERIC PROTEIN KINASE MODULATORS

The invention provides specific small molecule compounds that allosterically regulate the activity or modulate protein-protein interactions of AGC protein kinases and the Aurora family of protein kinases, methods for their production, pharmaceutical compositions comprising same, and their use for preparing medicaments for the treatment and prevention of diseases related to abnormal activities of AGC protein kinases or of protein kinases of the Aurora family.